المؤلفون: Koeberle, D. ^*, Dufour, J.-F., Demeter, G., Li, Q., Ribi, K., Samaras, P., Saletti, P., Roth, A.D., Horber, D., Buehlmann, M., Wagner, A.D., Montemurro, M., Lakatos, G., Feilchenfeldt, J., Peck-Radosavljevic, M., Rauch, D., Tschanz, B., Bodoky, G.

المصدر: In Annals of Oncology May 2016 27(5):856-861

المؤلفون: Samaras, Panagiotis, Breitenstein, S., Haile, S. R., Stenner-Liewen, F., Heinrich, S., Feilchenfeldt, J., Renner, C., Knuth, A., Pestalozzi, B. C., Clavien, P. A.

المصدر: Annals of Surgical Oncology. July 2011 18(7):1924-1931

المؤلفون: Power, D G, Feilchenfeldt, J

المساهمون: University of Zurich, Power, D G

مصطلحات موضوعية: 10032 Clinic for Oncology and Hematology, 2720 Hematology, 610 Medicine & health, 2730 Oncology

وصف الملف: mdp550.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=dedup_wf_001::c0110a3d42bf3aebd45444ff4738c172
http://doc.rero.ch/record/297668/files/mdp550.pdf

المؤلفون: Koeberle, D, Dufour, J-F, Demeter, G, Li, Q, Ribi, K, Samaras, P, Saletti, P, Roth, A D, Horber, D, Buehlmann, M, Wagner, A D, Montemurro, M, Lakatos, G, Feilchenfeldt, J, Peck-Radosavljevic, M, Rauch, D, Tschanz, B, Bodoky, G, Swiss Group for Clinical Cancer Research (SAKK)

المساهمون: University of Zurich, Koeberle, D

المصدر: Koeberle, D; Dufour, Jean-François; Demeter, G; Li, Q; Ribi, K; Samaras, P; Saletti, P; Roth, A D; Horber, D; Bühlmann, Michael; Wagner, A D; Montemurro, M; Lakatos, G; Feilchenfeldt, J; Peck-Radosavljevic, M; Rauch, D; Tschanz, B; Bodoky, G; Swiss Group for Clinical Cancer, SAKK (2016). Sorafenib with or without everolimus in patients with advanced hepatocellular carcinoma (HCC): a randomized multicenter, multinational phase II trial (SAKK 77/08 and SASL 29). Annals of oncology, 27(5), pp. 856-861. Oxford University Press 10.1093/annonc/mdw054 <http://dx.doi.org/10.1093/annonc/mdw054>

مصطلحات موضوعية: Sorafenib, Adult, Male, Niacinamide, medicine.medical_specialty, Carcinoma, Hepatocellular, Drug-Related Side Effects and Adverse Reactions, 2720 Hematology, 610 Medicine & health, Gastroenterology, Disease-Free Survival, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, medicine, Humans, Progression-free survival, Everolimus, Adverse effect, Aged, Neoplasm Staging, Aged, 80 and over, business.industry, Surrogate endpoint, Phenylurea Compounds, Liver Neoplasms, Hematology, Middle Aged, medicine.disease, Confidence interval, Surgery, Oncology, 030220 oncology & carcinogenesis, Hepatocellular carcinoma, 10032 Clinic for Oncology and Hematology, 030211 gastroenterology & hepatology, Female, 2730 Oncology, business, medicine.drug

وصف الملف: Sorafenib.pdf - application/pdf; application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07f2e8dbaf63744abc014d6cf05f3040
https://www.zora.uzh.ch/id/eprint/130783/

المؤلفون: Feilchenfeldt, J, Varga, Z, Siano, M, Grabsch, H I, Held, U, Schuknecht, B, Trip, A, Hamaguchi, T, Gut, P, Balague, O, Khanfir, K, Diebold, J, Jochum, W, Shoji, H, Kushima, R, Wagner, D, Shimada, Y, Cats, A, Knuth, A, Moch, H, Aebi, S, Hofer, S

المساهمون: University of Zurich

مصطلحات موضوعية: 10049 Institute of Pathology and Molecular Pathology, 610 Medicine & health, 2730 Oncology, 1306 Cancer Research

وصف الملف: Feilchenfeldt_BJC_2015.pdf - application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=od_______885::6b1846b5baf276b2075a5fa05885bb7a
https://www.zora.uzh.ch/id/eprint/117574/

المؤلفون: Merhi, M., Raza, A., Inchakalody, V., Sivaraman, S., Panayampilly, F., Mestiri, S., Hydrose, S., Allahverdi, N., Jalis, M., Relecom, A., Al Zaidan, L., Feilchenfeldt, J., Hamid, M.S. Elkhatim, Mostafa, M., Gul, A.R. Zar, Khan, S.U., Dermime, S.

المصدر: In Annals of Oncology December 2019 30 Supplement 11:xi41-xi41

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.

لا يتم عرض هذه النتيجة على الضيوف.
تسجيل الدخول للوصول الكامل.